BAYRY News and Press, Bayer AG ADR From 04/26/24

2024-04-26 14:35:34 ET More on Bayer Bayer AG (BAYZF) Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News (Rating Downgrade) Bayer: Long-Term Upside After The Dividend Cut Bayer dethroned as Germany’s top ...

2024-04-18 12:10:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. International markets ...

2024-04-16 12:23:16 ET More on Bayer, Bayer AG, etc. Bayer AG (BAYZF) Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News (Rating Downgrade) Bayer: Long-Term Upside After The Dividend Cut Google, Bayer in pact fo...

2024-04-11 07:45:23 ET More on Ginkgo Bioworks Ginkgo Bioworks: Multiple Red Flags Ginkgo Bioworks: More Awful Revenue Guidance Ginkgo Bioworks Holdings, Inc. 2023 Q4 - Results - Earnings Call Presentation Ginkgo Bioworks expands R&D tie-up with Novo Nord...

2024-04-10 04:00:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...

2024-04-09 10:27:56 ET More on Bayer, Bayer AG, etc. ChatGPT Is An Existential Threat To Google Search's Ad-Based Model Google Is Still A Long-Term Buy Amid Its Gemini Troubles Google: Gemini Controversy Provides AI Opportunity Dynatrace expands partnership w...

2024-04-09 10:25:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...

2024-04-07 08:00:00 ET More on Phathom Pharmaceuticals Phathom: Undervalued Biotech With Possible GERD Treatment Label Expansion Phathom Pharmaceuticals, Inc. (PHAT) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Phathom Pharmaceuticals ...

2024-04-05 16:43:51 ET More on Bayer Bayer Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News Bayer: Long-Term Upside After The Dividend Cut Read the full article on Seeking Alpha For further details see...

2024-03-25 13:07:32 ET Summary M&A activity in the biotech/biopharma sector is expected to remain active due to significant cash on Big Pharma's balance sheets, key patent expirations, and declining revenue from Covid related products. The oncology space continues to be a hot ...